Crawford Investment Counsel’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $839K | Sell |
3,250
-4,384
| -57% | -$1.13M | 0.01% | 216 |
|
|
2025
Q1 | $1.71M | Buy |
7,634
+461
| +6% | +$103K | 0.03% | 189 |
|
|
2024
Q4 | $1.64M | Buy |
7,173
+1,051
| +17% | +$240K | 0.03% | 191 |
|
|
2024
Q3 | $1.49M | Buy |
6,122
+80
| +1% | +$19.5K | 0.03% | 192 |
|
|
2024
Q2 | $1.16M | Buy |
6,042
+2
| +0% | +$383 | 0.02% | 189 |
|
|
2024
Q1 | $1.2M | Buy |
6,040
+524
| +9% | +$104K | 0.02% | 183 |
|
|
2023
Q4 | $949K | Buy |
+5,516
| New | +$949K | 0.02% | 191 |
|
|
2023
Q3 | – | Sell |
-1,001
| Closed | -$219K | – | 275 |
|
|
2023
Q2 | $219K | Hold |
1,001
| – | – | ﹤0.01% | 269 |
|
|
2023
Q1 | $219K | Sell |
1,001
-11
| -1% | -$2.41K | ﹤0.01% | 266 |
|
|
2022
Q4 | $211K | Hold |
1,012
| – | – | ﹤0.01% | 269 |
|
|
2022
Q3 | $221K | Sell |
1,012
-45
| -4% | -$9.83K | 0.01% | 263 |
|
|
2022
Q2 | $222K | Sell |
1,057
-121
| -10% | -$25.4K | ﹤0.01% | 268 |
|
|
2022
Q1 | $286K | Hold |
1,178
| – | – | 0.01% | 262 |
|
|
2021
Q4 | $307K | Sell |
1,178
-19
| -2% | -$4.95K | 0.01% | 256 |
|
|
2021
Q3 | $315K | Buy |
1,197
+6
| +0.5% | +$1.58K | 0.01% | 260 |
|
|
2021
Q2 | $294K | Buy |
1,191
+19
| +2% | +$4.69K | 0.01% | 260 |
|
|
2021
Q1 | $227K | Buy |
1,172
+11
| +0.9% | +$2.13K | 0.01% | 271 |
|
|
2020
Q4 | $247K | Buy |
+1,161
| New | +$247K | 0.01% | 256 |
|
|
2020
Q3 | – | Sell |
-1,161
| Closed | -$223K | – | 272 |
|
|
2020
Q2 | $223K | Buy |
+1,161
| New | +$223K | 0.01% | 252 |
|